Clinical Trials

A new study has demonstrated proof of concept for a Biolinq continuous sensor in preventing muscle loss during GLP-1 therapy. Investigators presented findings as a...

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System for...

FineHeart announced French regulators gave it the green light to initiate a first-in-human heart device trial in France. The French National Agency for the Safety...

NeuroPace announced preliminary one-year results from its Nautilus clinical study evaluating neuromodulation therapy for idiopathic generalised epilepsy (IGE). The company said the study met its...

Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface technology. The company evaluated the safety and feasibility of...

EnVVeno Medical announced three-year outcomes for its heart valve that it aims to submit to the FDA this year. The company (formerly Hancock Jaffe)...

Apreo Health announced its emergence from stealth and an upcoming presentation of first-in-human clinical data for its emphysema treatment. Menlo Park, California-based Apreo develops the...

LumiThera has released new topline data for its Valeda Light Delivery System treatment for slowing the progression of dry age-related macular degeneration (AMD). LumiThera’s Valeda...

Inquis Medical has reported that the single-arm trial of its Aventus thrombectomy system in treating individuals with acute intermediate-risk pulmonary embolism (PE) met its...